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Goldenhar syndrome (GS) results from an aberrant development of the 1st and 2nd branchial arches. There is a wide
range of clinical manifestations, the most common being microtia, hemifacial microsomia, epibulbar dermoids and
vertebral malformations. We present two cases of GS and secondary immunodeficiency due to anatomical defects
characteristic of this disorder. Case 1 (3-year-old female) averaged 6 episodes of sinusitis and otitis media per year.
Case 2 (7-year-old female) also had recurrent otitis media, an episode of bacterial pneumonia, and 2 episodes of
bacterial meningitis. Their immune evaluation included a complete blood count with differential, serum
immunoglobulin levels and specific antibody concentrations, lymphocyte phenotyping, and mitogen and antigen
responses, the results of which were all within normal ranges. Both children demonstrated major structural
abnormalities of the inner and middle ear structures, retention of fluid in mastoid air cells, and chronic sinusitis by
computed tomography. These two cases illustrate how a genetically-associated deviation of the middle ear cleft
can cause recurrent infections and chronic inflammation of the middle ear and adjacent sinuses, even meninges,
leading to a greatly reduced quality of life for the child and parents.
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Goldenhar syndrome (GS), also known as hemifacial
microsomia, oculo-auriculo-vertebral anomaly, dysplasia
or spectrum, results from an aberrant development of
the 1st and 2nd branchial arches [1]. There is a wide
range of clinical manifestations, the most common
being microtia, hemifacial microsomia, pre-auricular
skin tags, epibulbar dermoids, and vertebral malforma-
tions (Figure 1). Other skeletal abnormalities and ocular,
cardiac and renal anomalies have been described [2-4].
This condition has a prevalence ranging from 1:3500 to
1:7000 live births with a male to female ratio of 3:2
[2,5]. To our knowledge, there have been no case
reports of GS in association with immune deficiencies.
The etiology of GS remains unknown. It has been sug-
gested that a vascular insult and/or neural crest path-
ology during a critical time of embryogenesis could
account for this syndrome [6]. Some cases have been* Correspondence: sergedegolovine@aol.com; wtshearer@texaschildrens.org
1Section of Immunology, Allergy and Rheumatology, Department of
Medicine, Baylor College of Medicine, Houston, TX, USA
2Texas Children’s Hospital, Houston, TX, USA
Full list of author information is available at the end of the article
© 2012 De Golovine et al.; licensee BioMed Ce
Creative Commons Attribution License (http:/
distribution, and reproduction in any mediumreported to have autosomal dominant, autosomal reces-
sive and multifactorial inheritance patterns, however,
most GS cases are sporadic [7-9]. No chromosomal
errors or gene mutations have yet been detected in GS.
These two case presentations emphasize the import-
ance of anatomical deviations of middle ear and sinus
structures that impair proper drainage of secretions as
seen in GS that lead to a condition of secondary
immunodeficiency.Case presentation 1
A 3-year-old female child with GS was referred to the
Allergy and Immunology Clinic at Texas Children’s Hos-
pital for evaluation of recurrent infections. According to
the mother, the patient’s infections were diagnosed at
different private clinics by either pediatric or ear, nose,
and throat physicians with an average of 6 bouts of si-
nusitis and otitis media per year all requiring antibiotics.
The presence of otitis media and sinusitis was diagnosed
on the basis of fever, ear pain, and fetid greenish dis-
charge from the nostrils of the child. During the disease
free intervals, the patient had clear nasal discharge.ntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 7-year-old girl with Goldenhar Syndrome (Case Presentation 2): A, frontal view; B, left lateral view. The left lower side of the
face is underdeveloped and the external helix of the ear is misshapen with external ear tags.
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eral external ear canal stenosis, hypoacusia, pre-
auricular skin tags, left hemifacial microsomia, multiple
ventricular septal defects, and hypersegmented C2 and
C3 vertebrae. Her past surgical history included, bilateral
pre-auricular tag removal in May of 2009, right macro-
stomia repair with musculocutaneous flap transfer in
June of 2009, and right myringotomy with tube place-
ment in July of 2010. There was no family history of GS
or immune deficiencies.
The physical examination revealed a 3-year-old girl
with the classic GS findings. She was in the 5th and 10th
percentiles for weight and height, respectively. She had
bilateral malformed ears with left ear canal stenosis; a
right tympanostomy tube in the right tympanic mem-
brane with white discharge; and a pronounced down-
ward slant of the right side of the mouth. A computed
tomography (CT) scan of the sinuses showed the left
middle ear cavity and mastoid being diminished in size
and partially opacified. (Figure 2A)
Immune evaluation included a complete blood count
(CBC) with differential cell count, serum immunoglobu-
lin levels and specific antibody concentrations (measured
at 33 months of age, 15 months after vaccination with
diphtheria, tetanus, and acellular pertussis vaccine, and
pneumococcal 13-valent vaccine), lymphocyte phenotyp-
ing, and mitogen and antigen responses, the results of
which were all within normal ranges (Tables 1, 2).
Case presentation 2
A 7-year-old female child who was known to have GS and
bilateral sensorineural hearing loss was referred to theAllergy and Immunology Clinic at Texas Children’s Hos-
pital for evaluation of recurrent infections. She had an epi-
sode of bacterial meningitis 2 months before presentation.
At that time she was initially taken to an outside hospital
due to a 1 day history of vomiting, fever of 38.9° C, and
lethargy. With the suspicion of bacterial meningitis, she
was empirically treated with vancomycin, ceftriaxone, and
decadron 3 hours before a lumbar puncture revealed
purulent cerebral spinal fluid (CSF). CSF analysis was con-
sistent with bacterial meningitis, showing a cloudy fluid
with 2,815 white blood cells/mL (WBC) including 84%
segmented cells 9% lymphocytes, 7% monocytes, 15 red
blood cells/μL (RBC), a glucose of less than 5 mg/dL, and
a protein of 505 mg/dL. Analysis of the CSF proved nega-
tive for pneumococcal and meningococcal antigens, the
CSF gram stain did not reveal organisms, and the culture
remained negative. A CT scan of the head was also per-
formed and was reported as normal.
She was subsequently transferred to Driscoll Children’s
Hospital, Corpus Christi, Texas for further management
of her meningitis where a CBC showed a WBC count of
37,900 cells/μL, with 14% banded cells, 79% segmented
cells, 2% lymphocytes, and 1% atypical forms. The
hemoglobin concentration was 9.3 gm/dL, and the platelet
count was 452,000 cells/μL. On hospital day 2, the patient
developed left-sided neck pain and maintained her head
tilted towards the left side, raising concern for spinal/
epidural abscess. A CT scan of her neck failed to show
a spinal/epidural abscess, but was positive for a C2-C3
cervical fusion and a small arachnoid cyst at the left
posterior cranial fossa. In addition, partial opacification









Figure 2 CT scans of inner ear cavities and adjacent sinuses
performed at Texas Children’s Hospital. A, Case Presentation 1
showing diminished left middle ear cavity and mastoid sinus (yellow
arrow); B. Case Presentation 2 showing a dysplastic cochlea with an
abnormally large basal turn and only partially formed middle and to
a lesser extent apical turns (yellow arrow). The vestibule was also
dysplastic (not shown).
Table 1 Immune Cells, Serum Immunoglobulin, and
Specific Antibodies to Antigens in 2 patients with
Goldenhar Syndrome
Patient 1 Patient 2
3 y 7 y
WBC cells/μL 8930 (5,200–12,000) 14,080 (5,000–14,500)
Polymorphonuclear
leukocytes cells/μL
5340 (1,200–5,200) 8054 (1,500–8,563)
Lymphocytes cells/μL 2480 (2300–5400) 4731 (2,112–8,589)
IgG (mg/dL) 1140 (546–1454) 1174 (635–1284)
IgM (mg/dL) 102 (27–176) 209 (44–190)
IgA (mg/dL) 60.7 (59–269) 135 (32–191)
Diphtheria Toxoid IgG
(IU/mL)
1.5 (≥0.10) 8.8 (≥0.10)
Tetanus Toxoid IgG
(IU/mL)
1 (≥0.10) 0.2 (≥0.10)
Streptococcus Pneumoniae
Type 1 (μg/mL)
4.11 (≥1.3) 8.27 (≥1.3)
Streptococcus Pneumoniae
Type 3 (μg/mL
3.35 (≥1.3) 0.51 (≥1.3)
Streptococcus Pneumoniae
Type 4 (μg/mL)
8.91 (≥1.3) 9.31 (≥1.3)
Streptococcus Pneumoniae
Type 5 (μg/mL)
22.52 (≥1.3) 4.15 (≥1.3)
Streptococcus Pneumoniae
Type 6B (μg/mL)
14.03 (≥1.3) ≥ 37.83 (≥1.3)
Streptococcus Pneumoniae
Type 7F (μg/mL)
0.7 (≥1.3) 3.75 (≥1.3)
Streptococcus Pneumoniae
Type 8 (μg/mL)*
0.62 (≥1.3) 0.64 (≥1.3)
Streptococcus Pneumoniae
Type 9N (μg/mL) *
2.16 (≥1.3) 1.65 (≥1.3)
Streptococcus Pneumoniae
Type 9V (μg/mL)
3.77 (≥1.3) 4.25 (≥1.3)
Streptococcus Pneumoniae
Type 12F (μg/mL) *
0.56 (≥1.3) 0.43 (≥1.3)
Streptococcus Pneumoniae
Type 14 (μg/mL)
12.14 (≥1.3) 14.51 (≥1.3)
Streptococcus Pneumoniae
Type 18C (μg/mL)
9.85 (≥1.3) 14.35 (≥1.3)
Streptococcus Pneumoniae
Type 19F (μg/mL)
>59.27 (≥1.3) 29.2 (≥1.3)
Streptococcus Pneumoniae
Type 23F (μg/mL)
7.9 (≥1.3) 7.53 (≥1.3)
Age-related normal ranges in parenthesis are taken from Texas Children’s
Hospital, Houston, Texas.
*Antigens not contained in the 13-valent pneumococcal vaccine. Controls of
the day were run but not shown here.
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found (not shown). Of note, the patient had a right
cochlear implant since age 3 years. A careful review of
her CT scan at the time of her meningitis showed no
evidence of inflammatory changes surrounding the
right cochlear implant (not shown), making the im-
plant the cause of the meningitis much less likely.
The patient gradually improved, and was discharged
home after receiving 10 days treatment of ceftriaxone.
The patient’s diagnosis of GS was based on her char-
acteristic facial features (Figure 1). Genetic tests wereperformed but did not reveal any abnormalities. Her
past medical history was significant for recurrent ear
infection diagnosed by pediatricians, around 4–5 epi-
sodes per year and persistent ear fluid bilaterally, which
required tympanostomy tube placements and tonsill-
ectomy and adenoidectomy at age of 5. After the
Table 2 Peripheral Blood Mononuclear Cell Phenotyping of 2 patients with Goldenhar Syndrome
MONONUCLEAR CELL
PHENOTYPES
% OF TOTAL GATED POPULATION CELL COUNTS
PATIENT 1 PATIENT 2 PATIENT 1 PATIENT 2
3 y 7 y (#/mm^3) 3 y (#/mm^3) 7 y
CD45+ (Purity) 100.0 (100) 100.0 (100) 2483 (N/A) 1726 (N/A)
CD3-CD56,16+ 12.5 (3.0–18.6) 17 (5–21) 311 (123–785) 815 (128–474)
CD56+ 10.1 (6.2–23.2) 17 (6–23) 251 (137–478) 815 (137–478)
CD2+ 64.6 (69.8–93.2) 64 (70–93) 1604 (884–2800) 3068 (884–2800)
CD3+ (Total) 57.5 (58.0–74.0) 58 (56–76) 1427 (1656–3841) 2781 (991–2997)
CD3+CD4+ 39.6 (28.0–47.2) 33.9 (25–48) 983 (871–2379) 1625 (635–1620)
CD3+CD8+ 15.5 (16.0–31.8) 19 (16–43) 384 (518–1433) 911 (293–1221)
CD19+ 28.7 (12.8–30.6) 24 (11–28) 713 (421–1397) 1151 (249–865)
CD20+ 27.7 (2.7–24.9) 23 (3–25) 688 (59–457) 1103 (59–457)
CD19+CD27+ 2.1 (1.0–5.2) 1.9 (1–5) 52 (19–131) 91 (19–131)
HLA-DR+ 36.3 (8.9–36.4) 29 (9–36) 901 (177–692) 1390 (59–457)
CD4+CD45RA+ 27.6 (3.3–32.9) 24 (3–33) 686 (134–969) 1151 (134–969)
CD4+CD45RO+ 10.8 (15.6–41.8) 10 (16–42) 269 (301–919) 479 (301–919)
CD4/CD8 Ratio 2.56 (0.72–2.94) 1.78 (0.69–2.63) N/A N/A
Age-related normal ranges in parenthesis are taken from Allergy and Immunology Laboratory, Texas Children’s Hospital, Houston, Texas. Controls of the day were
run but not shown here.
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less frequency. She had one previous episode of menin-
gitis secondary to Streptococcus pneumoniae at
11 months of age, for which she was hospitalized for
10 days and received IV antibiotics. She was again hos-
pitalized for pneumonia requiring IV antibiotics at
2 years of age.
At the time of her visit to the Allergy and Immun-
ology Clinic at Texas Children’s Hospital, she was in the
75th and 50th percentiles of weight and height, respect-
ively. She had left hemifacial microsomia and bilateral
malformed ears with multiple ear tags. A CT scan of the
temporal bone performed 2 months prior to her menin-
gitis was reviewed and revealed inner ear malformations
including bilateral labyrinthine dysplasia and significant
hypoplasia of the right internal auditory canal. The left
cochlea was noted to be dysplastic (Figure 2B).
Her routine childhood immunizations were up to date
(diphtheria, tetanus, and acellular pertussis, and the
pneumococcal 13-valent vaccine given between 4 and
6 years), and she received the meningococcal vaccine
and another pneumococcal 13-valent vaccine prior to
discharge from Driscoll Children’s Hospital. Her im-
mune evaluation included a CBC with differential count,
immunoglobulin levels, specific antibody titers (mea-
sured at 7 years of age, 2 months after vaccination with
the 13-valent pneumococcal vaccine), lymphocyte phe-
notyping, mitogen and antigen responses, all reported to
be within normal ranges (Tables 1 and 2).The majority of secondary immunodeficiencies, such
as those illustrated by these two case presentations,
occur as the result of diseases or conditions extrinsic to
the immune system such as malnutrition, immunosup-
pressive agents, surgery and trauma, extremes of age, en-
vironmental factors, and genetic syndromes. Correction
of the primary defect usually leads to prevention or re-
versal of the related immune defect [10].
In addition, the combination of anatomical defects and
the capability of many pathogens of interfering with a
variety of immunological defenses create a vicious cycle
of epithelium-immune dysfunction with decrease in
pathogen clearance [10].
Examples of these anatomical defects are seen in
patients with Eustachian tube dysfunction and congeni-
tal anomalies such as Down syndrome, cleft palate,
Townes and oral-facial-digital syndromes, and the Di
George anomaly that are known to have a higher inci-
dence of recurrent or persistent otitis media. [11-14].
The basis for these recurrent infections in these patients
with abnormal otonasopharyngeal anatomy lies in their
inability to coordinate proper drainage of secretions and
bacteria particularly when tissues are acutely or chronic-
ally inflamed. With Down syndrome, stenotic ear canals
contribute to a marked increase in middle ear infusions
[12]. In the case of the partial Di George anomaly, where
patients have mild forms of T cell deficiency, bacterial
and viral infections are prolonged. Abnormal formations
of the palate predispose the Di George patient to
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cochlear dysplasia may develop a CSF fistula leading to
recurrent meningitis [15].
Conclusions
In summary, these two case presentations illustrate how
a genetic deviation of the middle ear cleft can cause re-
current infections of the middle ear and adjacent
sinuses, even meninges, leading to a greatly reduced
quality of life for the child and parents. The lack of
proper drainage of the middle ear and sinuses are most
likely the cause of repetitive infections despite normal
immune responses. Surgery and trauma that produce
anatomical dislocations are well accepted causes of sec-
ondary immunodeficiency leading into acute and chronic
infection due to the interruption of normal flow of body
secretions. Similar in principle, we believe, is the lack of
upper respiratory secretion clearance in these children
with Goldenhar syndrome.
Accordingly, we propose these two cases to be exam-
ples of secondary immunodeficiency related to anatom-
ical defects of the middle ear and auditory canals, where
an immune evaluation excluded primary immune defi-
ciencies. As in all of the secondary immune deficiencies,
we recommend correction of the causative illness, which
in this case would include surgical correction of the ana-
tomical defect with improvement of sinus drainage and
simultaneous antibiotic eradication of the pathogens.
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